Preclinical
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
The study tracked more than 250 veterans in over 600 visits at the Richard L. Roudebush VA Medical Center in Indianapolis, attempting to identify a molecule in the blood to track stress intensity. Over a decade, they evaluated gene expression in participants in both low- and high-stress states.
Data demonstrate platform feasibility to rapidly generate novel ADC combinations with superior stability
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
This year could be the big year for the company. Its chief executive officer and president, Isaac Ciechanover, is leaving the company by June 30, but says 2019 could be transformative.
Biotech and pharma companies from across the globe share data and news in a weekly roundup.
The study showed that artificial intelligence can be used to provide widespread, cost-effective eye screenings via telemedicine to assist ophthalmologists in improving vision outcomes.
New Haven, Conn.-based NextCure and the Yale University Office of Corporate Research (OCR) announced the publication of a study describing Siglec-15 (S15), a new target for immunotherapy. The article was published in the journal Nature Medicine.
Although cautious about using the word “cure,” researchers have described a second person globally to be cleared of HIV, the virus that causes AIDS. The new patient, who remains unnamed, is dubbed the “London Patient.”
An analysis of the genetics of nearly 95,000 people across the United States and Europe who have been diagnosed with Alzheimer’s disease has led to the discovery of four new genetic variants in the body that can increase the risk of developing the form of dementia.
PRESS RELEASES